German court upholds cancer treatment award
A Taiwanese pharmaceuticals company has failed to overturn an award in a billion-euro ICC dispute over a blood cancer drug based on allegations it was not allowed to fully defend itself.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.